Published in Blood Weekly, May 1st, 2008
"There was no evidence of a carcinogenic potential in mouse when administered for 26 consecutive weeks at levels up to 250...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.